The latest data point for RXRX's PEG Ratio in Q1'25 stands at 0.46, indicating a positive valuation signal relative to earnings growth, following a modest uptick from the negative -0.06 in Q4'24. This value suggests improving market perceptions of the company's growth prospects in the most recent reported quarter. Over the period from Q1'23 to Q1'25, the PEG Ratio has exhibited high volatility, starting at a deeply negative -1.63 in Q1'23, improving to -0.26 in Q2'23, and fluctuating through negative and positive territories, with a peak of 2.42 in Q1'24 before dropping sharply to -1.81 in Q2'24. Notable inflection points include the shift to positive territory in Q4'23 at 0.89 and the recent stabilization around 0.12 in Q4'25, reflecting an overall erratic trend driven by changing earnings expectations and stock multiples, while Q2'25 and Q3'25 show no data.